ResearcherCharles UniversityNo recent work listed
Marianna Borecká
Matched on ORCID iD 0000-0001-6413-222X; OpenAlex author ID A5060540331. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 4
- Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers13174430↗
- Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alteration… Co-author DOI 10.2147/cmar.s185352↗
- Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Co-author DOI 10.1016/j.cancergen.2016.03.003↗
- The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. Co-author DOI 10.1016/j.gene.2016.04.056↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zdeněk Kleibl · 4 shared papers, 2016–2021 · strength 0.29
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new… DOI 10.2147/cmar.s185352↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Markéta Janatová · 4 shared papers, 2016–2021 · strength 0.29
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new… DOI 10.2147/cmar.s185352↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Petra Kleiblová · 3 shared papers, 2016–2021 · strength 0.21
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Paper The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. DOI 10.1016/j.gene.2016.04.056↗
- Michal Vočka · 3 shared papers, 2016–2021 · strength 0.21
- Paper Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. DOI 10.3390/cancers13174430↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Paper The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. DOI 10.1016/j.gene.2016.04.056↗
- Pavel Souček · 3 shared papers, 2016–2019 · strength 0.19
- Paper Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new… DOI 10.2147/cmar.s185352↗
- Paper Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. DOI 10.1016/j.cancergen.2016.03.003↗
- Paper The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. DOI 10.1016/j.gene.2016.04.056↗
- Marta Kalousová · 1 shared paper, 2021 · strength 0.09
- Karen Paula Geboes · 1 shared paper, 2021 · strength 0.09
- Greet Wieme · 1 shared paper, 2021 · strength 0.09
- Kathleen Claes · 1 shared paper, 2021 · strength 0.09
- R Havlík · 1 shared paper, 2019 · strength 0.08
- Č Neoral · 1 shared paper, 2019 · strength 0.08
- Tomáš Zemánek · 1 shared paper, 2019 · strength 0.08
- Martin Loveček · 1 shared paper, 2019 · strength 0.08
- Bohuslav Melichar · 1 shared paper, 2019 · strength 0.08
- Viktor Hlaváč · 1 shared paper, 2019 · strength 0.08
- Beatrice Mohelníková-Duchoňová · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.